Material from the regrown tumor was collected to establish an isogenic model of carboplatin-resistant TNBC (C4O) and gene expression analysis revealed changes in Wnt signaling target AXIN2 and pluripotency and stem markers NANOG, OCT4, SOX2, and LGR5 (Figure 6B). The gene discussed is NANOG; the disease is neoplasm.